Cytokinetics | CYTK - Market Capitalization

Stock Price
65.47
Daily Change
-1.26 -1.89%
Monthly
4.89%
Yearly
81.91%
Q2 Forecast
64.72

Cytokinetics reported $7.73B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.52B 919M Dec/2025
Amgen USD 176.25B 24.32B Dec/2025
Arca Biopharma USD 1.47B 537M Dec/2025
Bayer EUR 36.36B 9.13B Dec/2025
Biogen USD 25.82B 5.28B Dec/2025
Brainstorm Cell Therapeutics USD 8M 3M Sep/2025
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Capricor Therapeutics USD 1.66B 1.33B Dec/2025
Cytokinetics USD 7.77B 1.19B Dec/2025
Eisai JPY 1.31T 140.95B Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Exelixis USD 11.75B 959M Dec/2025
Geron USD 843M 31M Dec/2025
Halozyme Therapeutics USD 7.91B 664M Dec/2025
Ionis Pharmaceuticals USD 12.81B 2.39B Dec/2025
Merck USD 261.26B 51.62B Dec/2025
Novartis USD 292.21B 26.55B Dec/2025
Pfizer USD 141.57B 6.48B Dec/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025